Atlassian

TEAM · Investment summary · as of 30 July 2026

Priced close to what the business has demonstrated

Portfolio decision

No position

Price · 30 July 2026

$98.12

12-month target

$116.58 +19%

Expected return

+11.5%

Next decision point

29 October 2026Results expected (estimated)

Business type: Inflection · scaling but economically observable

The business does not meet the quality standard for its economic type.

Investment view

At $98.12, TEAM requires a 5% five-year revenue growth rate to justify its enterprise value — less than the business already delivers, at 22%.

The strongest argument against this view: seat-count deflation in the software-developer base, compounded by AI-native displacement of issue tracking and collaboration, converting a seat-priced model from a growth engine into a per-seat deflation engine.

Underwriting bridge

Question	Evidence-based conclusion
What drives the business?	Not determined — the operating driver is not stated in one place
What do we forecast?	Revenue growth of 22% demonstrated; an exit multiple of 4.0x.
What does Street forecast?	Not determined — no consensus estimates are joined to this record
Where do we differ?	On revenue growth, the difference between what the price requires and what the business has demonstrated is +17.4 percentage points.
What is it worth?	Twelve-month target $116.58, +19% from the struck price. Scenario-weighted expected return net of costs +11.5%.
Why now?	Date not announced — no dated event that would resolve the disagreement is on file

What must go right

By Date not announced — no test date is stated for this conditionCustomers with more than $10,000 in Cloud ARR grow at least 8.0% year over year for two consecutive quartersWhere it stands: Not determined — no current reading of this metric is on file
By Date not announced — no test date is stated for this conditionCloud revenue grows at least 20% year over year in any quarter through FY2027Where it stands: Not determined — no current reading of this metric is on file
By Date not announced — no test date is stated for this conditionTrailing-twelve-month free cash flow margin falls at or above 15.0% for two consecutive quartersWhere it stands: Not determined — no current reading of this metric is on file

Catalysts and falsifiers

Date or window	Event	Thesis confirmed if	Thesis weakened or refuted if
29 October 2026	Next results (date estimated, not issuer-confirmed)	Revenue and margin in line with, or above, the house path	A miss that moves the full-year path below the guided floor

Dates marked as estimated are drawn from the company’s own reporting cadence, not from an announcement.

Risk and sell discipline

Impairment case

Seat-count deflation in the software-developer base, compounded by AI-native displacement of issue tracking and collaboration, converting a seat-priced model from a growth engine into a per-seat deflation engine. This is not a valuation bear case -- the multiple falls in this scenario BECAUSE the growth mechanism is gone, not as an independent assumption.

Estimated probability 18%, against the 30% level at which the position would be resized. It sits within that level.

Fundamental invalidation

Falsifiable and fundamental — not one of them is a price condition.

Customers with more than $10,000 in Cloud ARR grow less than 8.0% year over year for two consecutive quarters
Cloud revenue grows less than 20% year over year in any quarter through FY2027
Trailing-twelve-month free cash flow margin falls below 15.0% for two consecutive quarters
Trailing-twelve-month share repurchases fall below 80% of trailing-twelve-month stock-based compensation for two consecutive quarters

Price-based risk trigger

A daily close below $77.30 triggers an immediate review of the thesis and pauses additional buying. It is not an automatic sell unless a separate fundamental invalidation condition has been breached.

Upside sell discipline

On approach to the $116.58 target the case is reviewed rather than added to; a target reached is a reason to re-examine the position, not to hold it by default. The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.

Investment criteria

Criteria	Status	Investment meaning
Quality	Not met	Is the business worth owning under its declared economic type?
Valuation	Met	Is the operating path required by today's price achievable?
Liquidity	Met	Can the intended position be built and exited in the right vehicle?
Downside	Met	Seat-count deflation in the software-developer base, compounded by AI-native displacement of issue tracking and collaboration, converting a seat-priced model from a growth engine into a per-seat deflation engine.
Momentum	Not determined	Does price action support or complicate entry timing? Not established on the evidence on file.
Catalyst	Not determined	Is there a dated event that resolves the disagreement? Not established on the evidence on file.
Consensus	Not determined	Is the house-versus-Street disagreement identified and quantified? Not established on the evidence on file.

Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.

Bottom line

The strongest case for mispricing is that the business already delivers +17.4 percentage points more growth than the price requires. The most important unresolved uncertainty is the permanent-loss mechanism: seat-count deflation in the software-developer base, compounded by AI-native displacement of issue tracking and collaboration, converting a seat-priced model from a growth engine into a per-seat deflation engine. The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $77.30, which forces an immediate review.